Fig. 4From: Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling studyPredicted percentage of clinical malaria cases averted with RTS,S vaccination at age 6, 10 and 14 weeks and at age 6, 7-and-a-half and 9 months in children under 5 years of age (a) and in children under 10 years of age (b) for low (PP < 5 %), moderate (5 < PP < 40 %) and high transmission levels (PP > 40 %)Back to article page